GGrantIndex
← Leaderboards

Pappachan Kolattukudy

Ohio State University

Google Scholar ↗PubMed ↗ORCID ↗
$9,040,971
Attributed
$9,040,971
Total exposure
6
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1M · FY2005–13
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13

Funding mix

By agency

NIH$9,040,971 · 6

By mechanism

R01$8,685,971 · 4
R56$355,000 · 1
P30$0 · 1

Top collaborators

No co-investigators on record.

Most similar at Ohio State University

Same institution · by research overlap

Others in their field

Top investigators on “Mycobacterium Tuberculosis”

Research focus

Mycobacterium TuberculosisGene ExpressionLipid MetabolismLaboratory MouseFatty AcidsDrug ResistanceTuberculosisMacrophageMycobacterium SmegmatisGenesPlayVirulenceProteinsGenomeMutantProtein Structure FunctionLipidsCessation Of LifeCellsMonocyte Chemoattractant Protein 1PathogenLip StructureBiochemicalDrug Delivery Systems

Grant awards (32)

Lipid storage and mobilization in M. tuberculosis as antilatency drugs targets$343,564
R01 · FY2013 · AI · contact PI
Lipid storage and mobilization in M. tuberculosis as antilatency drugs targets$365,493
R01 · FY2012 · AI · contact PI
Lipid storage and mobilization in M. tuberculosis as antilatency drugs targets$366,827
R01 · FY2011 · AI · contact PI
Lipid storage and mobilization in M. tuberculosis as antilatency drugs targets$374,411
R01 · FY2010 · AI · contact PI
Lipid storage and mobilization in M. tuberculosis as antilatency drugs targets$380,958
R01 · FY2009 · AI · contact PI
MCPIP, a novel transcription factor in the development of heart failure$355,000
R56 · FY2009 · HL · contact PI
Search for novel TB Drug Targets in Lipid Metabolism$332,534
R01 · FY2008 · AI · contact PI
Search for novel TB Drug Targets in Lipid Metabolism$338,974
R01 · FY2007 · AI · contact PI
Molecular Biology of Unique Wall Lipids of Mycobacteria$273,076
R01 · FY2007 · AI · contact PI
Search for novel TB Drug Targets in Lipid Metabolism$349,099
R01 · FY2006 · AI · contact PI
Molecular Biology of Unique Wall Lipids of Mycobacteria$281,232
R01 · FY2006 · AI · contact PI
MCP-1 induced gene expression in cardiovascular disease$360,000
R01 · FY2005 · HL
Search for novel TB Drug Targets in Lipid Metabolism$357,500
R01 · FY2005 · AI
Molecular Biology of Unique Wall Lipids of Mycobacteria$288,000
R01 · FY2005 · AI
MCP-1 induced gene expression in cardiovascular disease$360,000
R01 · FY2004 · HL
Search for novel TB Drug Targets in Lipid Metabolism$358,750
R01 · FY2004 · AI
Molecular Biology of Unique Wall Lipids of Mycobacteria$288,000
R01 · FY2004 · AI
MCP-1 induced gene expression in cardiovascular disease$360,000
R01 · FY2003 · HL
GENES FOR METHY1-BRANCHED WALL LIPIDS AND TUBERCULOSIS$300,066
R01 · FY2003 · AI
Molecular Biology of Unique Wall Lipids of Mycobacteria$144,000
R01 · FY2003 · AI
MCP-1 induced gene expression in cardiovascular disease$358,750
R01 · FY2002 · HL
GENES FOR METHY1-BRANCHED WALL LIPIDS AND TUBERCULOSIS$295,887
R01 · FY2002 · AI
MOLECULAR BIOLOGY OF UNIQUE WALL LIPIDS OF MYCOBACTERIA$218,961
R01 · FY2002 · AI
MCP-1 induced gene expression in cardiovascular disease$10,000
R01 · FY2002 · HL
CORE--TRANSGENIC ANIMAL FACILITY$0
P30 · FY2002 · CA
GENES FOR METHY1-BRANCHED WALL LIPIDS AND TUBERCULOSIS$287,268
R01 · FY2001 · AI
MONOCYTE CHEMOATTRACTANT PROTEIN-1 AND ATHEROSCLEROSIS$284,608
R01 · FY2001 · HL
MOLECULAR BIOLOGY OF UNIQUE WALL LIPIDS OF MYCOBACTERIA$216,299
R01 · FY2001 · AI
CORE--TRANSGENIC ANIMAL FACILITY$0
P30 · FY2001 · CA
GENES FOR METHY1-BRANCHED WALL LIPIDS AND TUBERCULOSIS$304,104
R01 · FY2000 · AI
MONOCYTE CHEMOATTRACTANT PROTEIN-1 AND ATHEROSCLEROSIS$277,609
R01 · FY2000 · HL
MOLECULAR BIOLOGY OF UNIQUE WALL LIPIDS OF MYCOBACTERIA$210,001
R01 · FY2000 · AI